Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 79,995 |
|
|||||
| News | - | ||||||
| Day High | 2.35 | Low High |
|||||
| Day Low | 2.08 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immix Biopharma Inc | IMMX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.17 | 7.98% | 2.30 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.14 | 2.08 | 2.35 | 2.30 | 2.13 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 505 | 79,995 | $ 2.26 | $ 181,157 | - | 1.40 - 7.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:33:42 | 50 | $ 2.2516 | USD |
Immix Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 46.09M | 19.87M | - | 0 | -15.43M | -0.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immix Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMMX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.61 | 2.73 | 1.94 | 2.39 | 239,949 | -0.31 | -11.88% |
| 1 Month | 3.11 | 3.23 | 1.94 | 2.68 | 151,389 | -0.81 | -26.05% |
| 3 Months | 3.55 | 4.05 | 1.94 | 3.04 | 268,019 | -1.25 | -35.21% |
| 6 Months | 2.98 | 7.75 | 1.94 | 4.29 | 275,423 | -0.68 | -22.82% |
| 1 Year | 1.82 | 7.75 | 1.40 | 3.39 | 277,890 | 0.48 | 26.37% |
| 3 Years | 5.00 | 8.6799 | 0.68 | 4.16 | 1,203,227 | -2.70 | -54.00% |
| 5 Years | 5.00 | 8.6799 | 0.68 | 4.16 | 1,203,227 | -2.70 | -54.00% |
Immix Biopharma Description
| Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. |
